|
Review of the complaint history shows no similar complaint reported.Review of the mbr record of the lot number provided indicated that product was processed and released according to the product's acceptance criteria.Review of the incoming component qa (quality assurance) inspection reports showed to be acceptable (reference the component grid for lot code).All finished product testing results met specifications.The product is manufactured according to requirements of the device master record.The product is sterilized via filtration through sterilized silastic tubing filled into dry heat sterilized vials using a peristaltic pump.Finished product testing includes infrared adsorption, uf absorption, mnr, purity of pfno (gas chromatography), particulate analysis, bioburden and sterility.All testing for the batch associated with the reported lot met specifications.The product insert provides indications, instructions, and storage condition.Customer product storage and use could not be confirmed.Root cause could not be determined.Potential root causes include: solution quality issue ¿ unlikely, as chemistry and microbiology data was reviewed and was found to have met regulatory requirements prior to release.Consumer mishandling - no conclusion can be made regarding the contribution of consumer mishandling as this factor is outside the control of the manufacturing facility.Event related to consumer physiology ¿ no conclusion can be made regarding the contribution of unique consumer physiology as this factor is outside the control of the manufacturing facility.Surgical practices cannot be confirmed, (e.G.During injection, etc.).A comprehensive review was performed including review of the mbrs, complaint history, sanitization records, bioburden records, stability data, incoming component inspection results, in process finished products and environmental/utility samples.The review shows that the manufacturing processes were in a state of control.Based on acceptable mbr review, incoming component qa inspection testing results, and finished product inspection results, this lot continues to be acceptable.The manufacturer will continue to monitor data for evidence of adverse trending and take further action, as appropriate.The manufacturer internal reference number is: (b)(4).
|